<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20210119050079N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-06-13</date_registration>
      <primary_sponsor>Kermanshah University of Medical Sciences</primary_sponsor>
      <public_title>Comparison of the effect of 8 weeks of physical activity and mindfulness-based stress reduction program on psychological factors, sleep quality and  pattern in patients with major depression</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the effect of 8 weeks of physical activity and mindfulness-based stress reduction program on psychological factors, sleep quality and  pattern in patients with major depression (clinical trial study with a control group)</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-07-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/56552</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Patients are divided into four equal groups (1. physical activity, 2. mindfulness, 3. combination of physical activity and mindfulness and 4. control) based on a randomized ten-block design using random allocation software. To randomly assign 60 patients to the four groups, six different blocks of 10 different letters A and B and C and D, which indicate physical activity, mindfulness, combination of physical activity and mindfulness and control groups respectively, will be initially created. These blocks then will be numbered from one to ten. In the next step, each of these blocks will be randomly selected by performing lottery using 10 card with letters from 1 to 10 on them. Thus, in each lottery, by selecting a block, a combination of 6 letters of the letters A and B and C and D will be obtained. At the end of the 10 drawings, after selecting 10 blocks, a total of 60 letters A and B and C and D will be obtained. The resulting combination of letters A and B and C and D is single, and will be placed in 60 separate and sealed envelopes, respectively. following each patient recourse, an envelope will be opened to determine the group of that patient, Blinding description: Outcome examiners (people who distribute questionnaires among patients) are blind to the type of groups.</study_design>
      <phase>2</phase>
      <hc_freetext>Major depressive disorder.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: The group will receive aerobic exercise in two months. The exercises will include two parts: static aerobic exercise and dynamic aerobic exercise. In general, the exercises will consist of 4 main parts. 1) warm up; It will include stretching movements, hypothetical line movements, cross-arm movements, arm rotations, neck rotations, cross-leg movements, sit-ups, 2) static aerobic exercise; Includes climbers walking, Palank, Palank with knee touch, and ski movement. 3) Dynamic aerobic exercise; It will include jogging at 70% of your maximum heart rate. 4) cooling down; It will include stretching, cross-linking, sitting, lying down and cradle movement. Exercises are performed with behavioral techniques and with the guidance of sports instructors and in a modified manner in accordance with the physical fitness of patients. The intervention will done in 8 weeks and 2 sessions per week. Patients engage in aerobic exercise for 30 to 45 minutes per session. Intervention 2: Intervention group: The group will receive mindfulness based stress reduction program in two months. Mindfulness based stress reduction will done at 8 weeks and twice a week. The first week includes training and will discuss the MBSR and its potential for mental health. The second week is the stage of communication and conceptualization of mindfulness. The third week will include mindfulness training and dealing with obstacles. The fourth week of identifying values ​​is the distinction between value and purpose. The fifth week will be the practice of mindfulness and staying in the present. The sixth week will be devoted to cognitive, emotional and behavioral flexibility. The seventh week will be about creating a sense of acceptance and compassion in patients. Finally, in the eighth week, the composition and coherence of the components of mindfulness will be considered. Intervention 3: Intervention group: The group will receive combination of physical activity and mindfulness intervention in two months. Training on non-judgment and acceptance will be considered. Patients will learn to look at their goals and values without negative or positive judgments. Moreover, the physical activity will be considered as an training in the mindfulness intervention. In this way, the importance of physical activity as a factor in overcoming negative thoughts and reaching the present will be discussed. Patients will spend half of the treatment session on physical activity and the other half on the MBSR program. The intervention will done in 8 weeks and 2 sessions per week. Intervention 4: Control group: The group will receive Sertraline (Tolid Daro company) treatment in two months. Sertraline is prescribed at a dose of 50 to 200 mg per day as medication (control group). In addition, Patients are monitored by telephone twice a week in the control group. They are questioned about their physical and psychological condition.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is It is not yet known if there will be a plan to make this available</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Habibolah Khazaie</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Sleep Disorders Research Center, Farabi Hospital, Doulatabad Blvd., Kermanshah, Iran</address>
        <city>Kermanshah</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6719851151</zip>
        <telephone>+98 83 1824 9353</telephone>
        <email>hakhazaie@gmail.com</email>
        <affiliation>Kermanshah University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Habibolah Khazaie</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Farabi Hospital, Sleep Disorders Research Center, Department of Psychiatry, Kermanshah University of Medical Sciences, Dolatabad Blvd, PO box: 6719851151, Kermanshah, Iran</address>
        <city>Kermanshah</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>: 6719851151</zip>
        <telephone>+98 83 1824 9353</telephone>
        <email>hakhazaie@gmail.com</email>
        <affiliation>Kermanshah University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Major depression disorder diagnosed by a psychiatrist
Diagnosis of major depression disorder according to the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition: DSM-5 and Beck questionnaire
Have major depressive symptoms for at least 2 weeks</inclusion_criteria>
      <agemin>no limit</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Patients who are not agree to participate in the study will be excluded</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F32.2</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Major depressive disorder, single episode, severe without psychotic features</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Behavior</i_code>
      <i_code>Behavior</i_code>
      <i_code>Behavior</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: The group will receive aerobic exercise in two months. The exercises will include two parts: static aerobic exercise and dynamic aerobic exercise. In general, the exercises will consist of 4 main parts. 1) warm up; It will include stretching movements, hypothetical line movements, cross-arm movements, arm rotations, neck rotations, cross-leg movements, sit-ups, 2) static aerobic exercise; Includes climbers walking, Palank, Palank with knee touch, and ski movement. 3) Dynamic aerobic exercise; It will include jogging at 70% of your maximum heart rate. 4) cooling down; It will include stretching, cross-linking, sitting, lying down and cradle movement. Exercises are performed with behavioral techniques and with the guidance of sports instructors and in a modified manner in accordance with the physical fitness of patients. The intervention will done in 8 weeks and 2 sessions per week. Patients engage in aerobic exercise for 30 to 45 minutes per session.</i_keyword>
      <i_keyword>Intervention group: The group will receive mindfulness based stress reduction program in two months. Mindfulness based stress reduction will done at 8 weeks and twice a week. The first week includes training and will discuss the MBSR and its potential for mental health. The second week is the stage of communication and conceptualization of mindfulness. The third week will include mindfulness training and dealing with obstacles. The fourth week of identifying values ​​is the distinction between value and purpose. The fifth week will be the practice of mindfulness and staying in the present. The sixth week will be devoted to cognitive, emotional and behavioral flexibility. The seventh week will be about creating a sense of acceptance and compassion in patients. Finally, in the eighth week, the composition and coherence of the components of mindfulness will be considered.</i_keyword>
      <i_keyword>Intervention group: The group will receive combination of physical activity and mindfulness intervention in two months. Training on non-judgment and acceptance will be considered. Patients will learn to look at their goals and values without negative or positive judgments. Moreover, the physical activity will be considered as an training in the mindfulness intervention. In this way, the importance of physical activity as a factor in overcoming negative thoughts and reaching the present will be discussed. Patients will spend half of the treatment session on physical activity and the other half on the MBSR program. The intervention will done in 8 weeks and 2 sessions per week.</i_keyword>
      <i_keyword>Control group: The group will receive Sertraline (Tolid Daro company) treatment in two months. Sertraline is prescribed at a dose of 50 to 200 mg per day as medication (control group). In addition, Patients are monitored by telephone twice a week in the control group. They are questioned about their physical and psychological condition.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Symptoms of depression. Timepoint: before intervention- 8 weeks later- 4 weeks later. Method of measurement: Beck Questionnaire.</prim_outcome>
      <prim_outcome>Symptoms of anxiety. Timepoint: before intervention- 8 weeks later- 4 weeks later. Method of measurement: Beck Questionnaire.</prim_outcome>
      <prim_outcome>Perceived stress. Timepoint: before intervention- 8 weeks later- 4 weeks later. Method of measurement: Cohen Questionnaire.</prim_outcome>
      <prim_outcome>Emotion regulation. Timepoint: before intervention- 8 weeks later- 4 weeks later. Method of measurement: Emotion Regulation Problems Questionnaire.</prim_outcome>
      <prim_outcome>Sleep quality. Timepoint: before intervention- 8 weeks later- 4 weeks later. Method of measurement: Pittsburgh Questionnaire.</prim_outcome>
      <prim_outcome>Sleep pattern. Timepoint: before intervention- 8 weeks later- 4 weeks later. Method of measurement: Insomnia Severity Scale and sleep tables.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Kermanshah University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-05-15</approval_date>
        <contact_name>Kermanshah University of Medical Sciences</contact_name>
        <contact_address>Building No.2, Shahid Beheshti, Vice Chancellor for Research Affairs, Kermanshah University of Medical Sciences Kermanshah Kermanshah Kermanshah Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
